About us
About us
History
Corporate milestones
Leadership
R&D
Clinical trials
R&D achievements
Collaborations
Subsidiaries
News
Press releases
Events
ESG
Investors
Corporate governance
Financials
Shareholder services
Material information
FAQs
Careers
Join us
Learning and development
Compensation and benefit
Sustainable talents
Contact
LANGUAGE
繁體中文
簡體中文
English
SEARCH
Press Releases
Clarification Statement by Medigen and Its Subsidiary Yingshin Investment Co., Ltd. (Supplement)
2024/08/23
Clarification statement issued by Medigen Biotechnology Corp. and its subsidiary Yingshin Investment Co., Ltd.
(in Chinese)
Back To List